Abstract:ObjectivesPredictors for unfavorable treatment outcome in major depressive disorder (MDD) applicable fo treatment selection are still lacking. The database of a longitudinal multi‐center study on 1079 acutely depressed patients, performed by the German research network on depression (GRND), allows supervised and unsupervised learning to further elucidate the interplay of clinical and psycho‐sociodemographic variables and their predictive impact on treatment outcome phenotypes. Experimental ProceduresTreatment response was defined by a change of HAM‐D 17 item baseline score ≥ 50% and remission by the established threshold of ≤ 7, respectively after up to eight weeks of in‐patient treatment. After hierarchical symptom clustering and stratification by treatment subtypes (serotonin‐reuptake‐inhibitors, tricyclic antidepressants, antipsychotic and lithium augmentation) prediction models for different outcome phenotypes were computed with random forest in a cross‐center validation design. In total, 86 predictors were implemented. ResultsClustering revealed four distinct HAM‐D sub‐scores related to emotional, anxious, sleep and appetite symptoms, respectively. After feature selection classification models reached moderate to high accuracies up to 0.85. Highest accuracies were observed for the SSRI and TCA subgroups and for sleep and appetite symptoms while anxious symptoms showed poor predictability. ConclusionOur results support a decisive role for machine learning in the management of antidepressant treatment. Treatment‐ and symptom specific algorithms may increase accuracies by reducing heterogeneity. Especially predictors related to duration of illness, baseline depression severity, anxiety and somatic symptoms, and personality traits moderate treatment success. However, prospectives application of machine learning models will be necessary to prove their value for the clinic.

Combining machine learning algorithms for prediction of antidepressant treatment response